Immune-Mediated Inflammatory Diseases market to Exhibit an Incredible Growth Rate of 6.50 percent by 2029 - Benzinga
| AMPEDelisted Stock | USD 0.24 0.01 4.35% |
About 55% of Ampio Pharm's shareholders are presently thinking to get in. The analysis of overall sentiment of trading Ampio Pharm pink sheet suggests that some investors are interested at this time. The current market sentiment, together with Ampio Pharm's historical and current headlines, can help investors time the market. In addition, many technical investors use Ampio Pharm stock news signals to limit their universe of possible portfolio assets.
Ampio Pharm pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Ampio daily returns and investor perception about the current price of Ampio Pharm as well as its diversification or hedging effects on your existing portfolios.
Ampio |
Immune-Mediated Inflammatory Diseases market to Exhibit an Incredible Growth Rate of 6.50 percent by 2029 Benzinga
Read at news.google.com
 |
Ampio Pharm Fundamental Analysis
We analyze Ampio Pharm's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ampio Pharm using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ampio Pharm based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Probability Of Bankruptcy
Probability Of Bankruptcy Comparative Analysis
Ampio Pharm is currently under evaluation in probability of bankruptcy category among its peers. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
Ampio Pharm Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Ampio Pharm pink sheet to make a market-neutral strategy. Peer analysis of Ampio Pharm could also be used in its relative valuation, which is a method of valuing Ampio Pharm by comparing valuation metrics with similar companies.
Peers
Ampio Pharm Related Equities
| RNAZ | Transcode Therapeutics | 28.00 | ||||
| ZVSA | ZyVersa Therapeutics | 7.86 | ||||
| SONN | Sonnet Biotherapeutics | 7.02 | ||||
| PULM | Pulmatrix | 5.66 | ||||
| SYBX | Synlogic | 1.42 | ||||
| ACIU | AC Immune | 1.11 | ||||
| GLUE | Monte Rosa | 0.36 | ||||
| ANTX | AN2 Therapeutics | 0.79 | ||||
| CADL | Candel Therapeutics | 2.41 | ||||
| ZURA | Zura Bio | 3.91 | ||||
| AKTX | Akari Therapeutics | 4.92 | ||||
| PHIO | Phio Pharmaceuticals | 5.56 | ||||
| QNRX | Quoin Pharmaceuticals | 7.32 | ||||
| REVB | Revelation Biosciences | 21.88 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Consideration for investing in Ampio Pink Sheet
If you are still planning to invest in Ampio Pharm check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Ampio Pharm's history and understand the potential risks before investing.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |